drug · small molecule
patient view →ELTROMBOPAG OLAMINE
Marketedupdated 2mo agoby $AMRX Amneal Pharmaceuticals, Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 2 investigational indications.
targets
Thrombopoietin receptor
all catalysts(3)
approval · 3
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that